famotidine has been researched along with Pyrexia in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohseni, M | 1 |
| Raissi, V | 1 |
| Sharifan, Y | 1 |
| Barikro, K | 1 |
| Amiri, S | 1 |
| Mohseni, MS | 1 |
| Raeisi, F | 1 |
| Masoumi, K | 1 |
| Khodakarami, S | 1 |
| Raiesi, O | 1 |
| Norwood, J | 1 |
| Smith, TM | 1 |
| Stein, DS | 1 |
1 review available for famotidine and Pyrexia
| Article | Year |
|---|---|
Therapeutic Status of Famotidine in COVID-19 Patients: A Review.
Topics: COVID-19 Drug Treatment; Famotidine; Fever; Histamine; Humans; SARS-CoV-2 | 2022 |
1 other study available for famotidine and Pyrexia
| Article | Year |
|---|---|
Famotidine and hyperpyrexia.
Topics: Adult; Famotidine; Fever; Humans; Male | 1990 |